Average Co-Inventor Count = 7.82
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Metabolex, Inc. (8 from 41 patents)
2. Theravance, Inc. (7 from 386 patents)
3. Cymabay Therapeutics, Inc. (5 from 43 patents)
4. Genentech, Inc. (2 from 3,221 patents)
5. Advanced Medicine, Inc. (2 from 13 patents)
6. Kosan Biosciences Incorporated (1 from 110 patents)
7. International Business Machines Corporation (164,108 patents)
25 patents:
1. 9925189 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
2. 9737537 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
3. 8975258 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
4. 8921350 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
5. 8846675 - N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
6. 8288384 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
7. 8227495 - 2,4-disubsituted thiazoles and pharmaceutical compositions thereof
8. 8183381 - N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
9. 8063021 - Ketolide anti-infective compounds
10. 7723470 - Glycopeptide derivatives and pharmaceutical compositions containing the same
11. 7714131 - Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
12. 7638541 - 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
13. 7622491 - Modulators of PPAR and methods of their preparation
14. 7432394 - Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines
15. 7323480 - Substituted triazoles as modulators of PPAR and methods of their preparation